Skip to main content

Table 1 Demographics of each group in the study, mean values and standard deviation

From: Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker

  CT-noCa CT-plusCa AMI ANOVA
  n = 30 n = 30 n = 30 p-value
Age (yrs.) 60.2 60.3 64.5** 0.001
  [59.8; 60.7] [60.0; 60.6] [56.0; 73.0]  
Triglycerides A (mmol/L) 1.57 1.49 1.30 0.52
  [0.85; 2.93] [1.00; 2.21] [0.78; 2.19]  
HDL Cholesterol A (mmol/L) 1.28 1.36 1.13 0.07
  [0.93; 1.75] [0.98; 1.89] [0.83; 1.52]  
LDL Cholesterol (mmol/L) 3.14 3.26 2.93 0.47
  [2.13; 4.16] [2.29; 4.22] [1.74; 4.11]  
Total Cholesterol (mmol/L) 5.25 5.47 4.74 0.07
  [4.06; 6.43] [4.29; 6.64] [3.44; 6.04]  
Systolic Blood Pressure (mm Hg) 145 147 159* 0.03
  [131; 159] [128; 167] [132; 187]  
Diastolic Blood Pressure (mm Hg) 86 85 88 0.80
  [76; 95] [75; 96] [72; 103]  
Agatston score - 1299 - -
   [717; 2352]   
Heartscore A 5.29 6.38 8.00 0.07
  [2.89; 9.68] [2.96; 13.7] [4.01; 16.0]  
Osteopontin A 83 99 111 0.08
  [52; 132] [67; 145] [61; 201]  
Osteoprotegerin A 1583 1704 2170** 0.0007
  [1144; 2189] [1335; 2175] [1487; 3168]  
Fibulin A 63 63 78** 0.0006
  [49; 80] [50; 80] [62; 99]  
  1. CT-noCa: Asymptomatic individuals without detectable coronary calcium; CT-plusCa: Asymptomatic CVD with high coronary calcium; AMI (Acute Myocardial Infarction): patients with NSTEMI-ACS. Mean values [+/− STD)], A Geometric mean values [+/− STD)], and p-value from one-way of analysis of variance (ANOVA). The level of significance of p-values from comparison of each group against the control group ‘CT-noCa‘was adjusted for multiple comparisons by the method of Dunnet (*: p < 0.05; **: p < 0.01; ***: p < 0.001).